Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,179,287
+$5,253,496 QoQ
Shares Held
1,014,606
+40.0% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
3.23%
of 13F equity value
Holder Rank
#33
of 240 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Derivatives in SNDX
reported options exposure · as of Jun 30, 2020CallValue
$1,482,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $446,413,848 across 71 Biotechnology names. SNDX ranks #2 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
1,469,971 | $39,659,817 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
This page
|
1,014,606 | $22,179,287 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
588,494 | $19,649,814 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
328,550 | $18,799,631 | |
| 5 | CYTK |
Cytokinetics Inc
|
219,987 | $18,740,692 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
245,346 | $18,273,370 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
459,340 | $17,776,458 | |
| 8 | INSM |
INSMED Inc
|
118,800 | $12,666,456 |
All Filings in SNDX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,179,287 | 1,014,606 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,925,791 | 724,563 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,021,448 | 762,563 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,965,010 | 387,716 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,717,696 | 1,571,564 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,441,920 | 1,663,974 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $18,260,006 | 1,381,241 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $19,920,785 | 1,034,846 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,876,624 | 822,047 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $19,348,543 | 812,964 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,703,752 | 772,964 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $11,224,845 | 773,061 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $15,133,666 | 723,061 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,426,248 | 683,061 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $18,083,777 | 710,561 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,769,384 | 822,696 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,920,689 | 1,139,329 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $22,201,437 | 1,277,413 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,755,445 | 1,176,585 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,344,023 | 750,603 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,395,200 | 547,187 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $14,267,759 | 638,093 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,588,816 | 745,900 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,527,600 | 510,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,482,000 | 100,000 | Call | Defined | 2020-08-13 | |
| 2020-06-30 | $3,260,400 | 220,000 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $747,429 | 68,134 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||